"Medical leader" Hengrui PD-1 has been approved a clinical electronic drug license
It was found that Gleevec could improve the overall survival rate of CML patients
Beijing Intellectual property court adjudicates the administrative dispute over the invalidity of the patent right of Novartis' invention for medical purposes
Greavelli encounters a "battle for protection" of patent rights
Zhongyuan Xiehe will cooperate with Nobel Prize winners to build an international research and development platform for cell biotherapy
FDA approved votrient for advanced soft tissue sarcoma
Contact Us
Trade Alert - Delivering the latest product trends and industry news straight to your inbox.
(We`ll never share your email address with a third-party.)
鲁ICP备16009155号-1 | Copyright@Qingdao ECHEMI Technology Co., Ltd.
Welcome to ECHEMI